Purchase Order HHSF223201710592A
Award Date 9/27/17
Potential Completion Date 4/29/19
Potential Value $2.9M
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20910, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services Food and Drug Administration (FDA) awarded a sole-source, firm fixed-price purchase order contract to Nexight Group LLC, a regulatory consulting firm, to provide Standards Development for Regenerative Medicine Therapies. The contract has a potential value of $936,040.00 and a completion date of July 30, 2020. The FDA determined that Nexight Group's existing deliverables and expertise were required to ensure consistency and integrity of the overall...
- Nexight Group LLC, doing business as Nexight, was awarded a $1.8 million firm fixed price delivery order against its Multiple Award Schedule contract by the Department of Health and Human Services' Food and Drug Administration. The two-year contract calls for Nexight to provide standards development services to support the FDA's regenerative medicine therapies programs. Specifically, Nexight will assist the agency in developing standards for evaluating the safety and effectiveness of...
- The National Institute of Standards and Technology awarded a firm fixed-price purchase order to Standards Coordinating Body For Gene Cell & Regenerative Medicines for $2.214773 million on May 3, 2021, under Exercise Option III for standards development for regenerative medicine therapies. No set-aside applies. Work is performed in Gaithersburg, Maryland, with an ultimate completion date of May 2, 2026. The awardee is a non-profit organization specializing in standards development and...
- This is a federal contract award from the U.S. Department of Health and Human Services (HHS) to the National Academy of Sciences (NAS), a non-profit organization, for a contract titled "FORUM ON REGENERATIVE MEDICINE". The contract has a ceiling value of $441,145.04 and was awarded on September 2, 2015, with an ultimate completion date of December 31, 2018. It is a delivery order contract with a cost-no-fee pricing type. The award does not have a set-aside designation. NAS is a...
- The U.S. Department of Health and Human Services' Food and Drug Administration awarded a $15,000 firm fixed price purchase order to Sparrow Malcolm K. to conduct a "Risk-Informed Regulation Workshop" in Winchester, Massachusetts from August 4, 2023 through November 15, 2023. As the regulatory agency responsible for ensuring the safety and effectiveness of drugs, medical devices and other products, the FDA seeks to continually enhance its application of risk-based principles and risk...
- The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a sole-source contract to Nativas Sciences LLC, a self-certified small disadvantaged business, to purchase a Nativas DSM XPLORE 15 HT Microcompounder. The $165,021.00 firm-fixed-price purchase order contract is for the microcompounder, related accessories, and installation/training services. The contract has no set-aside designation and is scheduled for completion by September 1, 2025. This award was...
- <p>The Food and Drug Administration issued a purchase order to the National Academy of Sciences on September 18, 2024, valued at $100,000.00, for FDA support to the NASEM Leadership Consortium. The order is firm fixed price with no set-aside designation. Performance takes place in Washington, DC 20418. Ultimate completion is scheduled for September 29, 2025.</p>
- The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a $308,625.00 purchase order contract to NMD Group, LLC, a woman-owned small business, to support the FDA's planning for real-world data and real-world evidence related to COVID-19. The contract has a completion date of September 7, 2021 and is structured as a labor hours contract. This contract award appears to be part of the FDA's efforts to accelerate planning and utilization of real-world data and...
- The Department of Health and Human Services Health Resources and Services Administration awarded a Firm Fixed Price Delivery Order contract to Nexight Group LLC, a small business regulatory consulting firm, to provide TECHNICAL WRITING services for the SECRETARY'S REPORT TO CONGRESS ON NEWBORN SCREENING ACTIVITIES FOR 2021 AND 2022. The $55,600.00 contract was awarded on September 21, 2022 under the Multiple Award Schedule (MAS) contracting vehicle, with a completion date of March 20, 2024....
- The Department of Health and Human Services (HHS) National Institutes of Health (NIH) Clinical Center awarded a $198,597.49 firm-fixed-price purchase order contract to Life Technologies Corporation, a for-profit manufacturer, to supply specialized reagents and disposables to support the NIH's cellular therapy research and treatment programs. The contract is for a base year with three option years, providing reagents and supplies to enable the processing of approximately 100 cellular therapy...
The Department of Health and Human Services Food and Drug Administration awarded a firm fixed price purchase order to Nexight Group LLC, a regulatory consulting firm, for the development of standards for regenerative medicine therapies. The $2,921,928.00 contract supports the modification of an existing contract to add a workshop on reference materials and standards, publish fact sheets, and summarize relevant standards. Nexight has already established an organization of stakeholders and identified priority standards. This requirement was sole-sourced under FAR 6.302-1 as it is essential that the work build upon Nexight's prior efforts. The contract does not have a small business set-aside designation.
Generated 3/23/24, 4:17 PM
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Standards Development for Regenerative Medicine Therapies | FDA1204261 | Department of Health and Human Services Food and Drug Administration | Pre-Solicitation 1/2 | 9/10/18, 3:28 PM | |
Standards Development for Regenerative Medicine Therapies | FDA1204261 | Department of Health and Human Services Food and Drug Administration | Award Notice 2/2 | 10/11/18, 11:06 AM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| 3 | Other Administrative Action | $0 | 3/7/19 | |
| 2 | Additional Work (new agreement, FAR part 6 applies) | $555.0k | 9/26/18 | |
| 1 | Other Administrative Action | $0 | 11/3/17 | |
| Not listed | Not listed | $2.4m | 9/27/17 |